Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQGet Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totaling 34,933 shares, an increase of 81.8% from the June 15th total of 19,219 shares. Currently, 1.6% of the shares of the company are sold short. Based on an average trading volume of 35,762 shares, the short-interest ratio is presently 1.0 days.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Osaic Holdings Inc. raised its stake in shares of Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after buying an additional 1,052 shares in the last quarter. Ascentis Independent Advisors purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the first quarter valued at approximately $31,000. Royal Bank of Canada purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at approximately $37,000. International Assets Investment Management LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth $41,000. Finally, Advisory Services Network LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the third quarter worth $52,000.

Invesco Nasdaq Biotechnology ETF Stock Down 0.1%

Shares of Invesco Nasdaq Biotechnology ETF stock opened at $32.59 on Friday. Invesco Nasdaq Biotechnology ETF has a 52-week low of $21.87 and a 52-week high of $34.22. The company’s 50-day simple moving average is $30.64 and its 200-day simple moving average is $29.69. The firm has a market cap of $73.65 million, a price-to-earnings ratio of 17.03 and a beta of 0.60.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 26th. Shareholders of record on Monday, June 22nd were issued a $0.0342 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Monday, June 22nd.

Invesco Nasdaq Biotechnology ETF Company Profile

(Get Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.

See Also

Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.